tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Emmanuel Papadakis, 29 are a SELL (25.22%), 44 are a HOLD (38.26%), 42 are a BUY (36.52%).
Analyst Emmanuel Papadakis, currently employed at DEUTSCHE BANK, carries an average stock price target met ratio of 57.68% that have a potential upside of 46.83% achieved within 305 days.
Emmanuel Papadakis’s has documented 216 price targets and ratings displayed on 16 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ARGX, argenx NV ADR at 17-Jan-2025.
Analyst best performing recommendations are on ALVO (ALVOTECH).
The best stock recommendation documented was for MRNA (MODERNA) at 3/7/2022. The price target of $155 was fulfilled within 9 days with a profit of $28.54 (22.57%) receiving and performance score of 25.08.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$87
$10.79 (14.16%)
$78
3 months 13 days ago
(18-Nov-2024)
8/9 (88.89%)
$23.61 (37.25%)
588
Buy
$88
$11.79 (15.47%)
$82
3 months 18 days ago
(13-Nov-2024)
4/5 (80%)
$22.71 (34.78%)
297
Buy
$95
$18.79 (24.66%)
$66
6 months 19 days ago
(12-Aug-2024)
6/7 (85.71%)
$12.48 (15.12%)
382
Buy
$85
$8.79 (11.53%)
$80
9 months 1 days ago
(30-May-2024)
4/4 (100%)
$8.7 (11.40%)
391
Buy
$84
$7.79 (10.22%)
$85
10 months 9 days ago
(22-Apr-2024)
2/12 (16.67%)
$14.3 (20.52%)
163
Which stock is Emmanuel Papadakis is most bullish on?
Which stock is Emmanuel Papadakis is most reserved on?
What Year was the first public recommendation made by Emmanuel Papadakis?
